GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Diagnostic Medical Systems (XPAR:ALDMS) » Definitions » Return-on-Tangible-Asset

Diagnostic Medical Systems (XPAR:ALDMS) Return-on-Tangible-Asset : -7.93% (As of Jun. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Diagnostic Medical Systems Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Diagnostic Medical Systems's annualized Net Income for the quarter that ended in Jun. 2024 was €-2.86 Mil. Diagnostic Medical Systems's average total tangible assets for the quarter that ended in Jun. 2024 was €36.11 Mil. Therefore, Diagnostic Medical Systems's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2024 was -7.93%.

The historical rank and industry rank for Diagnostic Medical Systems's Return-on-Tangible-Asset or its related term are showing as below:

XPAR:ALDMS' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -26.6   Med: -11.32   Max: -2.88
Current: -26.6

During the past 13 years, Diagnostic Medical Systems's highest Return-on-Tangible-Asset was -2.88%. The lowest was -26.60%. And the median was -11.32%.

XPAR:ALDMS's Return-on-Tangible-Asset is ranked worse than
67.51% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: -2.355 vs XPAR:ALDMS: -26.60

Diagnostic Medical Systems Return-on-Tangible-Asset Historical Data

The historical data trend for Diagnostic Medical Systems's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnostic Medical Systems Return-on-Tangible-Asset Chart

Diagnostic Medical Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.63 -18.27 -10.80 -15.81 -11.84

Diagnostic Medical Systems Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.46 -12.93 17.06 -43.79 -7.93

Competitive Comparison of Diagnostic Medical Systems's Return-on-Tangible-Asset

For the Medical Devices subindustry, Diagnostic Medical Systems's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnostic Medical Systems's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Diagnostic Medical Systems's Return-on-Tangible-Asset falls into.



Diagnostic Medical Systems Return-on-Tangible-Asset Calculation

Diagnostic Medical Systems's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-4.946/( (46.196+37.355)/ 2 )
=-4.946/41.7755
=-11.84 %

Diagnostic Medical Systems's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=-2.864/( (37.355+34.856)/ 2 )
=-2.864/36.1055
=-7.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data.


Diagnostic Medical Systems  (XPAR:ALDMS) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Diagnostic Medical Systems Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Diagnostic Medical Systems's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnostic Medical Systems Business Description

Traded in Other Exchanges
Address
9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.

Diagnostic Medical Systems Headlines

No Headlines